Versant Venture Management
Versant Venture Management reported 8 stocks worth $163M in its 13F filing for Q2 2026, filed Aug 12, 2026. Its largest holdings are GLUE (47.3%), IPSC (18.3%) and JBIO (13.6%). Compared with Q1 2026, the fund trimmed JBIO.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  GLUE Monte Rosa Therapeutics Inc | $77M | 47.3% | 3.2M | No change | 7 of 8 | |
| 2 |  IPSC Century Therapeutics Inc | $29.8M | 18.3% | 12.2M | No change | 2 of 8 | |
| 3 |  JBIO Jade Biosciences Inc | $22M | 13.6% | 992K | −534K (−35%) | 5 of 8 | |
| 4 |  LENZ Lenz Therapeutics Inc | $15.1M | 9.3% | 2.7M | No change | 4 of 8 | |
| 5 |  CTNM Contineum Therapeutics Inc | $8.9M | 5.5% | 543K | No change | 8 of 8 | |
| 6 |  CRSP Crispr Therapeutics | $8.1M | 5.0% | 149K | No change | 8 of 8 | |
| 7 |  SKYE Skye Bioscience Inc | $1.4M | 0.9% | 2M | No change | 8 of 8 | |
| 8 |  TPST Tempest Therapeutics, Inc. | $299K | 0.2% | 270K | No change | 6 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 12, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Versant Venture Management 13F FAQ
What does Versant Venture Management own?
Versant Venture Management reported 8 stocks worth $163M in its 13F filing for Q2 2026, filed Aug 12, 2026. Its largest holdings are GLUE (47.3%), IPSC (18.3%) and JBIO (13.6%). The table above lists every position in the filing (the top 10 without an account).
What did Versant Venture Management buy and sell in Q2 2026?
Compared with Q1 2026: 0 new positions, 0 added to, 1 trimmed and 0 sold out.
When will Versant Venture Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Versant Venture Management's portfolio worth?
The Q2 2026 filing reports $163M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.